CIK: 0001720702
Total reported value
$73.2M
Reporting period: 2022-09-30 · Number of holdings: 4
Ponoi Management, LLC disclosed 4 holdings in its latest 13F filing for the period ending 2022-09-30, with total reported value of $73.2M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "P"
Sector classification currently covers about 18% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Rapt Therapeutics INC | Stock-Other | 52.54% | — | — | |
| 2 | NGMUSD | Ngm Biopharmaceuticals INC | Stock-Other | 23.20% | — | — | |
| 3 | RVMD | Revolution Medicines INC | Stock-Healthcare | 18.44% | — | — | |
| 4 | NRIX | Nurix Therapeutics INC | Stock-Other | 5.82% | — | — |
Not enough priced holdings yet to compute performance
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2022-09-30 | 4 | $73.2M | 0 | |
| 2022-06-30 | 4 | $63.3M | 0 | |
| 2022-03-31 | 4 | $77.0M | 0 | |
| 2021-12-31 | 4 | $108.5M | 0 | |
| 2021-09-30 | 4 | $112.6M | 0 | |
| 2021-06-30 | 5 | $180.0M | 34 | |
| 2021-03-31 | 5 | $170.0M | 12 | |
| 2020-12-31 | 5 | $174.8M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-11 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001727111
Total reported value
$73.2M
4 stks
2020-06-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001599950
Total reported value
$73.2M
141 stks
2025-09-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0002079812
Total reported value
$73.4M
255 stks
2026-03-31
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0001606074
Total reported value
$1.2B
11 stks
2020-09-30
Stale — no recent filing
4 of the top 5 holdings overlap, including Ngm Biopharmaceuticals INC
CIK 0001746488
Total reported value
$38.3M
4 stks
2022-09-30
Stale — no recent filing
4 of the top 5 holdings overlap, including Ngm Biopharmaceuticals INC
CIK 0000909661
Total reported value
$17.5B
172 stks
2026-03-31
1 of the top 5 holdings overlap, including Revolution Medicines INC